|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553(446)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mack GJ and Compton DA: Analysis of
mitotic microtubule-associated proteins using mass spectrometry
identifies astrin, a spindle-associated protein. Proc Natl Acad Sci
USA. 98:14434–14439. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Thein KH, Kleylein-Sohn J, Nigg EA and
Gruneberg U: Astrin is required for the maintenance of sister
chromatid cohesion and centrosome integrity. J Cell Biol.
178:345–354. 2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liu L, Akhter S, Bae JB, Mukhopadhyay SS,
Richie CT, Liu X and Legerski R: SNM1B/Apollo interacts with astrin
and is required for the prophase cell cycle checkpoint. Cell Cycle.
8:628–368. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Thedieck K, Holzwarth B, Prentzell MT,
Boehlke C, Kläsener K, Ruf S, Sonntag AG, Maerz L, Grellscheid SN,
Kremmer E, et al: Inhibition of mTORC1 by astrin and stress
granules prevents apoptosis in cancer cells. Cell. 154:859–874.
2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang YF, Zhang MF, Tian QH, Fu J, Yang X,
Zhang CZ and Yang H: SPAG5 interacts with CEP55 and exerts
oncogenic activities via PI3K/AKT pathway in hepatocellular
carcinoma. Mol Cancer. 17(117)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu H, Hu J, Wei R, Zhou L, Pan H, Zhu H,
Huang M, Luo J and Xu W: SPAG5 promotes hepatocellular carcinoma
progression by downregulating SCARA5 through modifying β-catenin
degradation. J Exp Clin Cancer Res. 37(229)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu JY, Zeng QH, Cao PG, Xie D, Yang F, He
LY, Dai YB, Li JJ, Liu XM, Zeng HL, et al: SPAG5 promotes
proliferation and suppresses apoptosis in bladder urothelial
carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway
and predicts poorer survival. Oncogene. 37:3937–3952.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu G, Liu S, Cao G, Luo W, Li P, Wang S
and Chen Y: SPAG5 contributes to the progression of gastric cancer
by upregulation of Survivin depend on activating the wnt/β-catenin
pathway. Exp Cell Res. 379:83–91. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yuan LJ, Li JD, Zhang L, Wang JH, Wan T,
Zhou Y, Tu H, Yun JP, Luo RZ, Jia WH and Zheng M: SPAG5
upregulation predicts poor prognosis in cervical cancer patients
and alters sensitivity to taxol treatment via the mTOR signaling
pathway. Cell Death Dis. 5(e1247)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Abdel-Fatah TMA, Agarwal D, Liu DX,
Russell R, Rueda OM, Liu K, Xu B, Moseley PM, Green AR, Pockley AG,
et al: SPAG5 as a prognostic biomarker and chemotherapy sensitivity
predictor in breast cancer: A retrospective, integrated genomic,
transcriptomic, and protein analysis. Lancet Oncol. 17:1004–1018.
2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang T, Li K, Song H, Xu D, Liao Y, Jing
B, Guo W, Hu M, Kuang Y, Sun B, et al: p53 suppression is essential
for oncogenic SPAG5 upregulation in lung adenocarcinoma. Biochem
Biophys Res Commun. 513:319–325. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li A, Wang Q, He G, Jin J and Huang G: DEP
domain containing 1 suppresses apoptosis via inhibition of A20
expression, which activates the nuclear factor κB signaling pathway
in HepG2 cells. Oncol Lett. 16:949–955. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sanchez-Vega F, Mina M, Armenia J, Chatila
WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia
S, et al: Oncogenic signaling pathways in the cancer genome atlas.
Cell. 173:321–37.e10. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357(eaan2507)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8(e82241)2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Välk K, Vooder T, Kolde R, Reintam MA,
Petzold C, Vilo J and Metspalu A: Gene expression profiles of
non-small cell lung cancer: Survival prediction and new biomarkers.
Oncology. 79:283–292. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Levine B and Kroemer G: Biological
functions of autophagy genes: A disease perspective. Cell.
176:11–42. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Song L, Dai Z, Zhang S, Zhang H, Liu C, Ma
X, Liu D, Zan Y and Yin X: MicroRNA-1179 suppresses cell growth and
invasion by targeting sperm-associated antigen 5-mediated Akt
signaling in human non-small cell lung cancer. Biochem Biophys Res
Commun. 504:164–170. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang L, Cao L, Wen C, Li J, Yu G and Liu
C: LncRNA LINC00857 regulates lung adenocarcinoma progression,
apoptosis and glycolysis by targeting miR-1179/SPAG5 axis. Hum
Cell. 33:195–204. 2020.PubMed/NCBI View Article : Google Scholar
|
